An inbred colony of oncogene transgenic mice: diversity of tumours and potential as a therapeutic model
1996

Transgenic Mice as a Model for Cancer Therapy

Sample size: 268 publication Evidence: moderate

Author Information

Author(s): H Thomas, AM Hanby, R-A Smith, P Hagger, K Patel, B Raikundalia, RS Camplejohn, FR Balkwill

Primary Institution: ICRF Biological Therapies Laboratory

Hypothesis

Can transgenic mice carrying the activated rat c-neu oncogene serve as a model for evaluating cancer therapies?

Conclusion

The study found that the transgenic mice developed a variety of tumors that resemble human cancers, suggesting their potential for evaluating novel therapies.

Supporting Evidence

  • 86 of 268 transgene-positive mice developed 93 diverse tumors.
  • The cumulative incidence of breast tumors at 24 months was 18%.
  • Breast tumors showed a range of architectural patterns resembling human cancers.
  • Transgene positivity declined with successive generations.
  • Virgin mice had fewer mammary tumors than those with two litters.

Takeaway

Scientists created special mice that can get different types of cancer to help test new medicines for treating cancer.

Methodology

Transgenic mice were backcrossed to BALB/c mice, and tumor development was monitored over several generations.

Limitations

Further genetic and environmental manipulations are needed to increase tumor incidence and decrease age of onset.

Participant Demographics

Transgenic female mice of mixed genetic backgrounds were used.

Statistical Information

P-Value

0.01

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication